Biologics Contract Development Market Share Value Projected to Cross USD 13.22 Billion by 2030: Polaris Market Research

NEW YORK, Nov. 9, 2022 /PRNewswire/ -- Polaris Market Research recently published [115+ Pages] research report on "Biologics Contract Development Market Share, Size, Trends, Industry Analysis Report, By Source (Mammalian, Microbial, Others); By Indication; By Product Service; By Region; Segment Forecast, 2022 - 2030" in its research database.

According to the research report, the global biologics contract development market size & share was valued at USD 5.48 billion in 2021 and is expected to reach USD 13.22 Billion by 2030, growing at a CAGR of 10.4% during the forecast period.

What is Biologics Contract Development? How Big is Biologics Contract Development Market Size & Share?

• Overview

The biologics contract development process provides clients seamless and efficient experience by lowering the cost of research and development. Biologics contract development organizations deliver biological, medical product development, and manufacturing services for pharma companies. Important services provided by these companies involve cell line development (MCB/WCB), upstream/down-stream process development, optimization and scale-up, stability studies and analytical characterization, regulatory guidance and support, structured project management, and process validation.

These services are majorly used by growing pharmaceutical and medical device industries offering services for biologics as well as small molecule drugs. Biologics contract development has become valuable resource for pharmaceutical firms, as they efficiently handle everything from pre-formulation to clinical trials and commercial production. Increasing outsourcing of R&D by pharma and biopharma businesses and growing adoption of new technologies for biological manufacturing are the key factors supporting the biologics contract development market size.

Request Sample Copy of "Biologics Contract Development Market" Research Report @ https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

Our Free Sample Report Includes

• Report introduction, overview, and in-depth industry analysis
• Breakdown data by regions, type, players, and applications
• Competitive landscape and leading competitor market shares
• 110+ pages research report
• Offers chapter-wise instruction on request
• Includes market presence across different geographies with share, size, and trends
• Updated list of tables and figures
• The report covers top players with their business strategies
• Factors and fact research methodology

Some of the Top Market Players Are:

• Abzena Ltd
• AGC Biologics
• Ajinomoto Bio-Pharma
• Almac
• Avid Bioservices Inc
• Bionova Scientific Inc
• BioXcellence (Boehringer Ingelheim Biopharmaceuticals GmbH)
• Curia Global Inc.
• Fujifilm Diosynth Biotechnologies
• Genscript
• KBI Biopharma
• LakePharma
• Lonza
• STC Biologics
• Samsung Biologics
• Thermo Fisher Scientific Inc.
• WuXi Biologics

To Know More About Addition Information on Key Players, Download a Report PDF Brochure

Growth Driving Factors

• Rising adoption of advanced technology, biological manufacturing flourishes, the market growth

Favorable regulatory environment for clinical trials in developing countries is one of the prominent factors driving the biologics contract development market demand. Governments in developing countries coordinate their policies with EMA and FDA standards to accelerate the authorization process and create reliability. This factor fuels the industry's growth. Growing adoption of advanced technology in biological manufacturing also propels industry development.

Furthermore, the escalating number of mergers and partnerships is expected to flourish the market growth. The industry is also booming owing to the growing prevalence of various disorders, including cancer, neurological disorders, and also cardiovascular diseases. In addition, recent research in new and combination therapies for developing biologics is further estimated to boost the biologics contract development market sales over the forecast period.

Directly Purchase a copy of report with TOC @ https://www.polarismarketresearch.com/checkouts/16581

Recent Developments

• In Jan 2022, Samsung Biologics announced the acquisition of Biogen's 50% stake as a joint venture to strengthen biosimilar development capabilities and future performance in novel drug development.
• In Oct 2021, Avid Bioservices announced the expansion into the development and manufacturing of viral vectors for cell and gene therapy.

Segmental Analysis

• The mammalian source held the largest market share

Based on source, mammalian source segment accounted for the largest biologics contract development market share and is expected to generate a significant CAGR over the forecast period. This is because using mammalian cells for protein expression provides a major advantage in developing mammalian proteins with accurate post-translational modifications. Most commonly used mammalian cell cultures to manufacture biopharmaceuticals includes Murine myeloma cells, baby hamster kidney (BHK21) cells, and Chinese hamster ovary (CHO) cells.

• The process development services segment held the biggest market share

On the basis of product service, the process development services segment led the market and is expected to dominate biologics contract development market forecasts. Biologics process development is defined by two techniques - upstream and downstream process development. Manufactures highly adopt the upstream process development to fulfill the client's requirements.

Request for Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market/request-for-discount-pricing

Biologics contract development market: Report Scope

Geographic Overview

• Biologics contract development market in North America is estimated to generate the fastest growth during the forthcoming period

On the basis of geography, North America dominated the market in 2021 owing to the rising strategic collaborations and acquisitions and a surged demand for specialized testing services. Also, increasing clinical trial activity and outsourcing activity are supporting the growth of contract development organizations (CDOs). Growing R&D investments and the local presence of leading players are further anticipated to fuel the regional industry growth.

The market in Asia Pacific is estimated to grow over the study period. This can be attributed to the rising investment by biotechnology companies in the Asia Pacific region due to various regulatory organization modifications to change clinical trial evaluation guidelines according to global requirements. 

Browse the Detail Report "Biologics Contract Development Market Share, Size, Trends, Industry Analysis Report, By Source (Mammalian, Microbial, Others); By Indication; By Product Service; By Region; Segment Forecast, 2022 - 2030" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/biologics-contract-development-market  

For Additional Information OR Media Enquiry, Please Mail At: [email protected]

Polaris Market Research has segmented the biologics contract development market report based on source, product service, indication, and region:

By Source Outlook

• Microbial
• Mammalian
• Others

By Product Service Outlook

• Cell Line Development
• Microbial
• Mammalian
• Others
• Process Development
• Upstream
• Microbial
• Mammalian
• Others
• Downstream
• Impurity, isolation & identification
• Physicochemical Characterization
• Pharmaceutical Analysis
• Others
• By Product
• MABs
• Recombinant Proteins
• Others
• Others

By Indication Outlook

• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

By Region Outlook

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Related Reports:

• Capsule Endoscopy Market: https://www.polarismarketresearch.com/industry-analysis/capsule-endoscopy-market
• Myopia and Presbyopia Treatment Market: https://www.polarismarketresearch.com/industry-analysis/myopia-presbyopia-treatment-market
• Post Harvest Treatment Market: https://www.polarismarketresearch.com/industry-analysis/post-harvest-treatment-market
• Cold Plasma Market: https://www.polarismarketresearch.com/industry-analysis/cold-plasma-market
• Prostate Health Market: https://www.polarismarketresearch.com/industry-analysis/prostate-health-market

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: [email protected]
Web: https://www.polarismarketresearch.com 
Follow US: LinkedIn | twitter

Logo; https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jpg

SOURCE Polaris Market Research